![](/img/cover-not-exists.png)
P-777 Phase I study of combination irinotecan and cisplatin and either twice daily thoracic radiation (45Gy) or once daily thoracic radiotherapy (70Gy) in patients with limited small cell lung carcinoma (SCLC): Early toxicity analysis of RTOG 0241
Langer, C., Swann, S., Werner-Wasik, M., Lillenbaum, R., Curran, W., Sandler, A., Scidmore, N., Choy, H., Samuels, M.Volume:
49
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/S0169-5002(05)81270-X
Date:
July, 2005
File:
PDF, 141 KB
english, 2005